Andres McAllister
Chief Tech/Sci/R&D Officer at BIOINVENT INTERNATIONAL AB
Net worth: 7 128 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Björn Frendéus | M | 51 | 23 years | |
| Martin Welschof | M | 63 | 6 years | |
| Leonard Kruimer | M | 66 | 8 years | |
| Alexandre Maret | M | - |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 19 years |
| Kristoffer Bissessar | M | 56 | 6 years | |
| Cecilia Hofvander | F | - | 3 years | |
| Stefan Ericsson | M | 61 | 26 years | |
| Vincent Ossipow | M | 55 | 8 years | |
| Emma Meurling | F | - | - | |
| Martin Pålsson | M | 45 | 2 years | |
| Marie Moores | F | - | 2 years | |
| Natalie Berner | F | 34 | 2 years | |
| Ingunn Munch Lindvig | M | - | 1 years | |
| Bernd Seizinger | M | 67 | 6 years | |
| Sylvie Ryckebusch | M | - | 2 years | |
| Kristoffer Rudenholm Hansson | M | 50 | 8 years | |
| David Luc Deperthes | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 12 years |
| Nanna Liebach Lüneborg | M | 49 | 2 years | |
| Erik Esveld | M | - | 3 years | |
| Thomas O. Hecht | M | 73 | 4 years | |
| Elin Birgersson | F | 39 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Oredsson | M | 64 | 5 years | |
| Lars Ingelmark | M | 75 | 12 years | |
| Alf Gunnar Martin Nicklasson | M | 69 | 1 years | |
| Jane M. Birgitta Stymne Göransson | F | 67 | 2 years | |
| Oengus Ramsay | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Ulrika T. Mattson | F | 56 | 10 years | |
| An van Es-Johansson | M | 64 | 5 years | |
| Elin Jaensson Gyllenbäck | M | 45 | - | |
| Nigel McCracken | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 5 years |
| Kamel Besseghir | M | 75 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 17 years |
| Niklas Prager | M | 54 | 1 years | |
| Pierre Kairouz | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | - |
| Dharminder Singh Chahal | M | 48 | 10 years | |
| Anette Martensson | F | 42 | - | |
| Louise Cavalli | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 30 | 83.33% |
| Switzerland | 6 | 16.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andres McAllister
- Personal Network